Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ktorza

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
British Journal of Pharmacology|October 2, 1998
Potent antihyperglycaemic property of a new imidazoline derivative S-22068 (PMS 847) in a rat model of NIDDMA Pelé-Tounian, X Wang, F Rondu, et al.
Journal of Medicinal Chemistry|November 26, 1997
Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 1. Synthesis and biological activities of N-benzyl-N'-(arylalkyl)-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines F Rondu, G Le Bihan, X Wang, et al.
Journal of Medicinal Chemistry|May 7, 1999
Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 2. Syntheses and biological activities of 1,4-dialkyl-, 1,4-dibenzyl, and 1-benzyl-4-alkyl-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines and isosteric analogues of imidazolineG Le Bihan, F Rondu, A Pelé-Tounian, et al.
European Journal of Pharmacology|August 17, 1999
Effect of the new imidazoline derivative S-22068 (PMS 847) on insulin secretion in vitro and glucose turnover in vivo in ratsA Pelé-Tounian, S L Chan, F Rondu, et al.
Diabetes, Obesity & Metabolism|August 1, 2015
Pancreatic β-cell imaging in humans: fiction or option?D Laurent, L Vinet, S Lamprianou, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
British Journal of Pharmacology|October 2, 1998
Potent antihyperglycaemic property of a new imidazoline derivative S-22068 (PMS 847) in a rat model of NIDDMA Pelé-Tounian, X Wang, F Rondu, et al.
Journal of Medicinal Chemistry|November 26, 1997
Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 1. Synthesis and biological activities of N-benzyl-N'-(arylalkyl)-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines F Rondu, G Le Bihan, X Wang, et al.
Journal of Medicinal Chemistry|May 7, 1999
Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 2. Syntheses and biological activities of 1,4-dialkyl-, 1,4-dibenzyl, and 1-benzyl-4-alkyl-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines and isosteric analogues of imidazolineG Le Bihan, F Rondu, A Pelé-Tounian, et al.
European Journal of Pharmacology|August 17, 1999
Effect of the new imidazoline derivative S-22068 (PMS 847) on insulin secretion in vitro and glucose turnover in vivo in ratsA Pelé-Tounian, S L Chan, F Rondu, et al.
Diabetes, Obesity & Metabolism|August 1, 2015
Pancreatic β-cell imaging in humans: fiction or option?D Laurent, L Vinet, S Lamprianou, et al.
Pageof 7